Immusoft Closes First Part of Series B Financing, New CEO to Lead Gene Therapy Company

PRESS RELEASE: Immusoft Corporation, a Seattle, Wash.-based gene therapy company, announced today it has closed a $3M initial tranche of a Series B financing. The full Series B is underway. The round is expected to provide Immusoft the funding it needs...